mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.001 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.002 |
mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
-0.27 |
0.002 |
mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.002 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.002 |
mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.002 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.002 |